BeyondSpring Pharmaceuticals to Present Today at 4th Annual Cancer Biopartnering & Investment Forum in NYC
February 24, 2016 08:30 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Feb. 24, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals’ Data Indicating Plinabulin Enhances Immune Response Provides Basis for Planned Phase I/II Combination Trial in NSCLC
February 08, 2016 08:30 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Feb. 08, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals to Present at 18th Annual BIO CEO & Investor Conference
February 03, 2016 08:30 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Feb. 03, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals to Present at 8th Annual Biotech Showcase
January 07, 2016 08:00 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Jan. 07, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals and Fred Hutchinson Cancer Research Center Enter Collaboration Agreement
January 06, 2016 09:51 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Jan. 06, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals to Present Plinabulin-Immune System Interactions at AACR’s 2016 Tumor Microenvironment Special Conference
January 05, 2016 10:32 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Jan. 05, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals Granted CTA by CFDA to Initiate China Arm of Global Phase III Trial of Lead Asset Plinabulin
December 21, 2015 16:00 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Dec. 21, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies,...
BeyondSpring Data Demonstrating Activity of Plinabulin in Kras-Mutant Tumors Presented at AACR-NCI-EORTC International Conference 2015
November 17, 2015 08:00 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Nov. 17, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring Announces Appointments of Dr. Ramon Mohanlal as Chief Medical Officer and Robert Dickey IV as Chief Financial Officer
October 30, 2015 07:00 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Oct. 30, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring Announces Positive Follow-Up Results for Phase 2 Trial of Plinabulin in Advanced NSCLC at WCLC 2015
September 15, 2015 10:19 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Sept. 15, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...